Qualigen Therapeutics, Inc (QLGN)

CARLSBAD, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announced the closing of its previously announced registered direct offering with certain institutional investors for the purchase and sale of 5,880,000 shares of common stock for $1.50 per share (i.e., for aggregate gross proceeds of $8,820,000). A.G.P./Alliance Global Partners acted as sole placement agent for the offering. The securities were sold pursuant to an effective shelf registration st

CARLSBAD, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutic products for the treatment of cancer, as well as maintaining and expanding its flagship FastPack® diagnostic platform, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of 5,880,000 shares of the Company’s common stock at a purchase price of $1.50 per share pursuant to a

Gainers Krystal Biotech (NASDAQ:KRYS) shares moved upwards by 118.21% to $86.87 during Monday's regular session. ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips I hope you got your rest out over the holiday weekend because we're starting off Monday with the biggest pre-market stock movers! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced ...

Gainers Biofrontera (NASDAQ:BFRI) shares increased by 160.83% to $6.86 during Wednesday's regular session. The company's market cap ...

Gainers Biofrontera Inc. (NASDAQ: BFRI) shares jumped 109.5% to $5.51 after Roth Capital initiated coverage on the stock with a ...

Following the market opening Wednesday, the Dow traded down 0.30% to 35,706.59 while the NASDAQ fell 0.61% to 15,678.70. The S&P ...

Gainers Ocuphire Pharma (NASDAQ:OCUP) stock rose 78.73% to $6.22 during Wednesday's pre-market session. The market ...

Gainers Engine Gaming and Media, Inc. (NASDAQ: GAME) rose 51% to $4.80 in pre-market trading after the company reported Q4 2021 ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're starting the last day of this short holiday week with a dive into the biggest pre-market stock movers for Wednesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 162.8% to close at $17.03 after the company announced a clinical ...

Gainers Biolase (NASDAQ:BIOL) shares increased by 25.69% to $0.53 during Tuesday's after-market session. Today's trading volume for ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Here's what investors may want to know about preclinical biotech firm Qualigen as QLGN stock absolutely skyrockets today. The post QLGN Stock Alert: 7 Things to Know as Qualigen Rockets Higher appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 228.5% to $7.26 during Tuesday's regular session. The company's ...

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) shares jumped 216.6% to $7.00 after the company announced its subsidiary ...

Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 157.46% to $5.69 during Tuesday's pre-market session. ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investors! We're getting right back to the grind today with a dive into the biggest pre-market stock movers for Tuesday. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

Qualigen Therapeutics Inc(NASDAQ: QLGN) shares are trading higher after a Zack's Small Cap research note showed a $9 price ...

Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 201% to $4.00 in pre-market trading. The company filed proxy statement ...

Gainers Qualigen Therapeutics (NASDAQ:QLGN) stock moved upwards by 43.2% to $1.79 during Monday's after-market session. At the close, ...

By David Bautz, PhD NASDAQ:QLGN READ THE FULL QLGN RESEARCH REPORT Financial Update On November 15, 2021, Qualigen Therapeutics, Inc. (NASDAQ:QLGN) announced financial results for the third quarter of 2021. The company reported $1.2 million in revenues for the third quarter of 2021, compared to $0.8 million for the three months ending September 30, 2020. The increase was primarily due to a

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Quarterly revenues increased 38% to approximately $1.2 million, compared to approximately $0.8 million in the same quarter of the previous yearYear-to-date revenues increased 30% to $4.2 million, compared to $3.2 million in the same nine-month period of the previous yearCash equivalents of approximately $12.3 million as of September 30, 2021 CARLSBAD, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeu

CARLSBAD, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, today announces the publication of a study in the peer-reviewed, open-source journal, Diagnostics, validating the Company’s point of care FastPack® IP (“FastPack”) diagnostic test as comparable to an industry-leading laboratory method in determining thyroid stimulating h